PV
Peregrine Ventures
Venture CapitalActivePeregrine Ventures, Israel's leading venture capital fund for early stage investments, is focused on investing in promising early stage
75
Investments
8
Exits
$1.2B
AUM
10.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Peregrine Ventures.
Investment Thesis & Strategy
Peregrine Ventures invests in promising early-stage companies across enterprise, health diagnostics, life science, and healthcare sectors, with a focus on Israeli startups. They target various stages of investment.
Investment Activity
Deals per year over the last 19 years
1
20000
20010
20020
20030
20040
20051
20060
20071
20080
20091
20103
20111
20120
20130
20140
20151
20160
20171
2018Portfolio Companies
Selected investments from their portfolio of 75 companies
X
XACT Robotics
Robotics · Growth, 2018
A
Alpha Tau Medical
Healthcare · Growth, 2016
N
NanoCyte
Biotech · Growth, 2012
C
CartiHeal
Healthcare · Growth, 2011
M
Medi-Tate
Healthcare · Growth, 2011
S
SpineGuard
Healthcare · Growth, 2011
V
Valeritas
Healthcare · Growth, 2010
I
Impulse Dynamics
Healthcare · Growth, 2008
I
InspireMD
Healthcare · Growth, 2006
B
BioLineRx
Biotech · Growth, 2000
Notable Exits
CompanyTypeYearValue / Acquirer
ValeritasIPO2018—
Impax LaboratoriesAcquisition2018—
NeuroDermAcquisition2017$1.1B
XenoPortAcquisition2016—
OphthotechIPO2013—
GI DynamicsIPO2013—
D-PharmAcquisition2010—
BioLineRxIPO2007—
Frequently Asked Questions
Peregrine Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Gulliver Investment Group
Or Yehuda, Israel · 0 deals
Bessemer Venture Partners
Redwood City, United States · 971 deals
Threshold
Menlo Park, United States · 841 deals
Lightspeed Venture Partners
Menlo Park, United States · 839 deals
Index Ventures
San Francisco, United States · 827 deals
Andreessen Horowitz
Menlo Park, United States · 826 deals